Sagimet Biosciences
SGMT
SGMT
70 hedge funds and large institutions have $44.9M invested in Sagimet Biosciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
12.14% less ownership
Funds ownership: 57.04% → 44.9% (-12%)
43% less capital invested
Capital invested by funds: $78.8M → $44.9M (-$33.8M)
Holders
70
Holding in Top 10
2
Calls
$539K
Puts
$436K
Top Buyers
| 1 | +$1.13M | |
| 2 | +$792K | |
| 3 | +$474K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$165K |
| 5 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$150K |
Top Sellers
| 1 | -$9M | |
| 2 | -$2.29M | |
| 3 | -$1.83M | |
| 4 |
Millennium Management
New York
|
-$1.74M |
| 5 |
6CM
683 Capital Management
New York
|
-$622K |